1. Home
  2. PGEN vs SNFCA Comparison

PGEN vs SNFCA Comparison

Compare PGEN & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

SELL

Current Price

$7.73

Market Cap

2.8B

Sector

Health Care

ML Signal

SELL

Logo Security National Financial Corporation

SNFCA

Security National Financial Corporation

SELL

Current Price

$9.13

Market Cap

229.2M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
PGEN
SNFCA
Founded
1998
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
229.2M
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
PGEN
SNFCA
Price
$7.73
$9.13
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $13.65
N/A
AVG Volume (30 Days)
★ 4.3M
23.0K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 13.51
EPS
0.03
★ 0.60
Revenue
$230,981,000.00
★ $344,587,538.00
Revenue This Year
$2,365.68
N/A
Revenue Next Year
$85.75
N/A
P/E Ratio
$273.67
★ $14.67
Revenue Growth
N/A
★ 3.01
52 Week Low
$2.99
$7.70
52 Week High
$8.98
$10.23

Technical Indicators

Market Signals
Indicator
PGEN
SNFCA
Relative Strength Index (RSI) 52.37 61.35
Support Level $6.41 $9.14
Resistance Level N/A $9.40
Average True Range (ATR) 0.51 0.19
MACD 0.01 0.05
Stochastic Oscillator 38.06 79.73

Price Performance

Historical Comparison
PGEN
SNFCA

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About SNFCA Security National Financial Corporation

Security National Financial Corp is a holding company providing insurance services. The company operates in three reportable business segments: Life insurance, Cemetery and Mortuary, and Mortgages. The life insurance segment sells and services selected lines of life insurance, annuity products, and accident and health insurance. The cemetery and mortuary segment engages in pre-need selling of funeral, cemetery, mortuary, and cremation services through its cemetery and mortuary locations. The mortgage segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and other real estate projects. It derives the majority of revenue from Life Insurance segment.

Share on Social Networks: